Answers are grounded in this paper and cite their sources.
In vivo and in vitro findings demonstrate improved dry eye symptoms and enhanced wound healing.
The ophthalmic solution containing CX-CMC and SP was effective in improving dry-eye signs and symptoms in patients and in absorbing UV and blue light. Furthermore, the ophthalmic solution promoted wound healing in vitro. Collectively, the results suggest that CX-CMC and SP eye drops could serve as a promising tool for treating dry eye disease of various origins.
No takes yet. Share an insight, caveat, or question.
Scarinci et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: